XSWX:GALE (Switzerland)
Business Description
Galenica Ltd.
Untermattweg 8, Bern, CHE, 3027
Compare
Compare
Traded in other countries / regions
G70.Germany
•
GALE.Switzerland
•
0ROG.UK
•
GALNF.USA
Description
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is primarily operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.49 | |||||
| Debt-to-EBITDA | 1.97 | |||||
| Interest Coverage | 37.76 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.23 | |||||
| Beneish M-Score | -2.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | 25.2 | |||||
| 3-Year EPS without NRI Growth Rate | 4.1 | |||||
| 3-Year FCF Growth Rate | 29 | |||||
| 3-Year Book Growth Rate | 9.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 2.56 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.8 | |||||
| 9-Day RSI | 37.71 | |||||
| 14-Day RSI | 43.61 | |||||
| 6-1 Month Momentum % | 18.62 | |||||
| 12-1 Month Momentum % | 10.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.45 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.25 | |||||
| Days Inventory | 37.62 | |||||
| Days Sales Outstanding | 42.9 | |||||
| Days Payable | 42.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.86 | |||||
| Dividend Payout Ratio | 0.53 | |||||
| 3-Year Dividend Growth Rate | 2.9 | |||||
| Forward Dividend Yield % | 2.86 | |||||
| 5-Year Yield-on-Cost % | 2.86 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.24 | |||||
| Operating Margin % | 4.94 | |||||
| Net Margin % | 4.37 | |||||
| ROE % | 14.87 | |||||
| ROA % | 6.85 | |||||
| ROIC % | 7.98 | |||||
| ROC (Joel Greenblatt) % | 31.08 | |||||
| ROCE % | 11.62 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.71 | |||||
| Forward PE Ratio | 21.79 | |||||
| PE Ratio without NRI | 21.91 | |||||
| Price-to-Owner-Earnings | 11.55 | |||||
| PEG Ratio | 1.38 | |||||
| PS Ratio | 0.96 | |||||
| PB Ratio | 2.97 | |||||
| Price-to-Tangible-Book | 17.55 | |||||
| Price-to-Free-Cash-Flow | 13.34 | |||||
| Price-to-Operating-Cash-Flow | 10.94 | |||||
| EV-to-EBIT | 19.61 | |||||
| EV-to-Forward-EBIT | 19.97 | |||||
| EV-to-EBITDA | 13.3 | |||||
| EV-to-Forward-EBITDA | 13.7 | |||||
| EV-to-Revenue | 1.07 | |||||
| EV-to-Forward-Revenue | 1.04 | |||||
| EV-to-FCF | 15.07 | |||||
| Price-to-Projected-FCF | 1.31 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.37 | |||||
| Price-to-Graham-Number | 4.11 | |||||
| Earnings Yield (Greenblatt) % | 5.1 | |||||
| Forward Rate of Return (Yacktman) % | 20.32 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 3,834.679 | ||
| EPS (TTM) (CHF) | 3.38 | ||
| Beta | 0.49 | ||
| Volatility % | 18.74 | ||
| 14-Day RSI | 43.61 | ||
| 14-Day ATR (CHF) | 1.840411 | ||
| 20-Day SMA (CHF) | 75.775 | ||
| 12-1 Month Momentum % | 10.19 | ||
| 52-Week Range (CHF) | 60.55 - 79 | ||
| Shares Outstanding (Mil) | 49.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galenica Ltd. Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||